Mazor Robotics (NASDAQ:MZOR) was upgraded by research analysts at Vetr from a “sell” rating to a “hold” rating in a note issued to investors on Monday. The brokerage presently has a $74.27 target price on the medical instruments supplier’s stock. Vetr‘s price objective indicates a potential downside of 0.74% from the company’s previous close.
MZOR has been the subject of a number of other reports. BidaskClub lowered Mazor Robotics from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. Zacks Investment Research lowered Mazor Robotics from a “buy” rating to a “hold” rating in a research note on Saturday, January 13th. Barclays reiterated a “sell” rating and set a $36.00 price objective on shares of Mazor Robotics in a research note on Tuesday, January 9th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research note on Wednesday, February 14th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $48.75.
Shares of Mazor Robotics (NASDAQ MZOR) traded up $3.19 during midday trading on Monday, hitting $74.82. The company had a trading volume of 597,743 shares, compared to its average volume of 552,242. The firm has a market capitalization of $1,910.00, a price-to-earnings ratio of -146.71 and a beta of 1.18. Mazor Robotics has a twelve month low of $22.32 and a twelve month high of $76.40.
A number of institutional investors have recently added to or reduced their stakes in MZOR. Oracle Investment Management Inc. raised its stake in Mazor Robotics by 13.0% during the fourth quarter. Oracle Investment Management Inc. now owns 2,816,635 shares of the medical instruments supplier’s stock worth $28,617,000 after acquiring an additional 323,724 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Mazor Robotics in the fourth quarter valued at $2,594,000. Menta Capital LLC increased its stake in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the medical instruments supplier’s stock valued at $466,000 after buying an additional 16,879 shares in the last quarter. UBS Group AG increased its stake in shares of Mazor Robotics by 28.8% in the first quarter. UBS Group AG now owns 34,164 shares of the medical instruments supplier’s stock valued at $425,000 after buying an additional 7,641 shares in the last quarter. Finally, Iguana Healthcare Management LLC increased its stake in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the medical instruments supplier’s stock valued at $1,507,000 after buying an additional 96,151 shares in the last quarter. Hedge funds and other institutional investors own 24.09% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Mazor Robotics (MZOR) Raised to Hold at Vetr” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/03/12/mazor-robotics-mzor-raised-to-hold-at-vetr.html.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.